Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

NASDAQ:MHUA - Nasdaq - KYG5966G1082 - Common Stock - Currency: USD

0.4  -0.05 (-11.15%)

After market: 0.42 +0.02 (+5%)

Fundamental Rating

5

MHUA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MHUA had positive earnings in the past year.
MHUA had a positive operating cash flow in the past year.
Each year in the past 5 years MHUA has been profitable.
In multiple years MHUA reported negative operating cash flow during the last 5 years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.35%, MHUA belongs to the top of the industry, outperforming 91.44% of the companies in the same industry.
MHUA has a Return On Equity of 9.79%. This is amongst the best in the industry. MHUA outperforms 85.56% of its industry peers.
MHUA's Return On Invested Capital of 9.47% is amongst the best of the industry. MHUA outperforms 91.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MHUA is in line with the industry average of 7.89%.
The last Return On Invested Capital (9.47%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.35%
ROE 9.79%
ROIC 9.47%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

MHUA's Profit Margin of 10.94% is amongst the best of the industry. MHUA outperforms 85.56% of its industry peers.
In the last couple of years the Profit Margin of MHUA has declined.
With an excellent Operating Margin value of 14.20%, MHUA belongs to the best of the industry, outperforming 83.42% of the companies in the same industry.
MHUA's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 34.08%, MHUA is not doing good in the industry: 71.66% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of MHUA has declined.
Industry RankSector Rank
OM 14.2%
PM (TTM) 10.94%
GM 34.08%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
Compared to 1 year ago, MHUA has more shares outstanding
The number of shares outstanding for MHUA has been increased compared to 5 years ago.
Compared to 1 year ago, MHUA has about the same debt to assets ratio.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.06 indicates that MHUA is not in any danger for bankruptcy at the moment.
MHUA's Altman-Z score of 3.06 is fine compared to the rest of the industry. MHUA outperforms 70.05% of its industry peers.
MHUA has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
The Debt to FCF ratio of MHUA (0.55) is better than 93.58% of its industry peers.
MHUA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, MHUA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.55
Altman-Z 3.06
ROIC/WACC1.42
WACC6.66%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.26 indicates that MHUA has no problem at all paying its short term obligations.
MHUA has a better Current ratio (5.26) than 77.01% of its industry peers.
MHUA has a Quick Ratio of 5.21. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.21, MHUA belongs to the top of the industry, outperforming 80.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.26
Quick Ratio 5.21
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

1

3. Growth

3.1 Past

MHUA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.57%.
MHUA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.75% yearly.
MHUA shows a decrease in Revenue. In the last year, the revenue decreased by -2.09%.
MHUA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.01% yearly.
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.73 indicates a rather cheap valuation of MHUA.
Based on the Price/Earnings ratio, MHUA is valued cheaper than 99.47% of the companies in the same industry.
MHUA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.15.
Industry RankSector Rank
PE 0.73
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than MHUA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.88
EV/EBITDA -0.15
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of MHUA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MHUA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (6/30/2025, 8:00:01 PM)

After market: 0.42 +0.02 (+5%)

0.4

-0.05 (-11.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners1.06%
Inst Owner Change32.51%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap12.76M
AnalystsN/A
Price TargetN/A
Short Float %0.09%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.73
Fwd PE N/A
P/S 0.09
P/FCF 0.88
P/OCF 0.87
P/B 0.08
P/tB 0.08
EV/EBITDA -0.15
EPS(TTM)0.55
EY137.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.45
FCFY113.66%
OCF(TTM)0.46
OCFY114.71%
SpS4.46
BVpS4.98
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.35%
ROE 9.79%
ROCE 12.71%
ROIC 9.47%
ROICexc 10.48%
ROICexgc 10.51%
OM 14.2%
PM (TTM) 10.94%
GM 34.08%
FCFM 10.2%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexcg growth 3Y-27.75%
ROICexcg growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.55
Debt/EBITDA 0.38
Cap/Depr 23.41%
Cap/Sales 0.09%
Interest Coverage 81.6
Cash Conversion 70.46%
Profit Quality 93.21%
Current Ratio 5.26
Quick Ratio 5.21
Altman-Z 3.06
F-Score4
WACC6.66%
ROIC/WACC1.42
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.01%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%